Protein kinase CK2 catalyzes tyrosine phosphorylation in mammalian cells

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Protein kinase CK2 (CK2) is known for its oncogenic activity and overexpression in various cancers.
• Traditionally classified as a serine/threonine kinase, CK2's potential tyrosine kinase activity has been suggested but not definitively proven in mammalian cells.

Purpose of the Study:

• To provide definitive evidence that CK2 possesses tyrosine kinase activity in mammalian cells.
• To investigate the characteristics and substrates of CK2-mediated tyrosine phosphorylation.
• To explore the implications of CK2's tyrosine kinase activity in cellular transformation and cancer.

Main Methods:

• Investigating tyrosine phosphorylation of CK2 in cells and immunoprecipitates using CK2 activity assays and a selective inhibitor (4,5,6,7-tetrabromobenzotriazole).
• Analyzing phosphotyrosine profiles in cells with varying CK2 levels.
• Utilizing peptide arrays to determine specificity determinants for CK2's tyrosine phosphorylation.

Main Results:

• Definitive evidence was obtained showing CK2 exhibits tyrosine kinase activity in mammalian cells.
• CK2 tyrosine phosphorylation is dependent on its own activity and inhibited by 4,5,6,7-tetrabromobenzotriazole.
• Increased CK2 levels led to elevated tyrosine phosphorylation of multiple proteins, including CK2 itself.
• CK2's tyrosine phosphorylation specificity differs from its serine/threonine phosphorylation, notably requiring an aspartic acid C-terminal to the tyrosine residue.

Conclusions:

• CK2 catalyzes tyrosine phosphorylation in mammalian cells, adding complexity to its known functions.
• This dual kinase activity suggests CK2 may play a broader role in cellular signaling.
• The findings raise the possibility that CK2's elevated levels in transformed cells contribute to increased tyrosine phosphorylation observed in cancer.